Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern

被引:1
|
作者
Xiao, Yanyu [1 ]
Chen, Shengyuan [2 ]
Zhu, Yi [3 ]
McCarthy, Zachary [2 ,3 ]
Bragazzi, Nicola Luigi [2 ,3 ]
Asgary, Ali [4 ]
Wu, Jianhong [2 ,3 ]
机构
[1] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA
[2] York Univ, Dept Math & Stat, Toronto, ON, Canada
[3] York Univ, Dept Math & Stat, Lab Ind & Appl Math, Toronto, ON, Canada
[4] York Univ, Sch Adm Studies & Adv Disaster & Emergency Rapid, Disaster & Emergency Management, Toronto, ON, Canada
关键词
COVID-19; variants of concern; vaccine roll-out; optimal reopening pathway; optimization; mathematical model;
D O I
10.3389/fpubh.2021.729141
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We developed a stochastic optimization technology based on a COVID-19 transmission dynamics model to determine optimal pathways from lockdown toward reopening with different scales and speeds of mass vaccine rollout in order to maximize social economical activities while not overwhelming the health system capacity in general, hospitalization beds, and intensive care units in particular. We used the Province of Ontario, Canada as a case study to demonstrate the methodology and the optimal decision trees; but our method and algorithm are generic and can be adapted to other settings. Our model framework and optimization strategies take into account the likely range of social contacts during different phases of a gradual reopening process and consider the uncertainties of these contact rates due to variations of individual behaviors and compliance. The results show that, without a mass vaccination rollout, there would be multiple optimal pathways should this strategy be adopted right after the Province's lockdown and stay-at-home order; however, once reopening has started earlier than the timing determined in the optimal pathway, an optimal pathway with similar constraints no longer exists, and sub-optimal pathways with increased demand for intensive care units can be found, but the choice is limited and the pathway is narrow. We also simulated the situation when the reopening starts after the mass vaccination has been rolled out, and we concluded that optimal pathways toward near pre-pandemic activity level is feasible given an accelerated vaccination rollout plan, with the final activity level being determined by the vaccine coverage and the transmissibility of the dominating strain.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Investigating the FLiRT variants of COVID-19: Is it an emerging concern?
    Aden, Durre
    Zaheer, Sufian
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [2] Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants
    Sah, Pratha
    Vilches, Thomas N.
    Moghadas, Seyed M.
    Fitzpatrick, Meagan C.
    Singer, Burton H.
    Hotez, Peter J.
    Galvani, Alison P.
    [J]. ECLINICALMEDICINE, 2021, 35
  • [3] Covid-19: What is happening with the vaccine rollout?
    Limb, Matthew
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 372 : n213
  • [4] Prioritizing the marginalized in the COVID-19 vaccine rollout
    Braganza, Brent B.
    Capulong, Harvey Gain M.
    Gopez, Jose Ma W.
    Gozum, Ivan Efreaim A.
    Galang, Joseph Renus F.
    [J]. JOURNAL OF PUBLIC HEALTH, 2021, 43 (02) : E368 - E369
  • [5] COVID-19 vaccine design and vaccination strategy for emerging variants
    Chavda, Vivek P.
    Apostolopoulos, Vasso
    [J]. EXPERT REVIEW OF VACCINES, 2022, 21 (10) : 1359 - 1361
  • [6] Covid-19 variants of concern and pregnancy
    Stock, Sarah J.
    Harmer, Clea
    Calvert, Clara
    [J]. BMJ MEDICINE, 2022, 1 (01):
  • [7] Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness
    Shaver, Nicole
    Katz, Melanie
    Asamoah, Gideon Darko
    Linkins, Lori-Ann
    Abdelkader, Wael
    Beck, Andrew
    Bennett, Alexandria
    Hughes, Sarah E.
    Smith, Maureen
    Begin, Mpho
    Coyle, Doug
    Piggott, Thomas
    Kagina, Benjamin M.
    Welch, Vivian
    Colijn, Caroline
    Earn, David J. D.
    El Emam, Khaled
    Heffernan, Jane
    'Brien, Sheila F. O.
    Wilson, Kumanan
    Collins, Erin
    Navarro, Tamara
    Beyene, Joseph
    Boutron, Isabelle
    Bowdish, Dawn
    Cooper, Curtis
    Costa, Andrew
    Curran, Janet
    Griffith, Lauren
    Hsu, Amy
    Grimshaw, Jeremy
    Langlois, Marc-Andre
    Li, Xiaoguang
    Pham-Huy, Anne
    Raina, Parminder
    Rubini, Michele
    Thabane, Lehana
    Wang, Hui
    Xu, Lan
    Brouwers, Melissa
    Horsley, Tanya
    Lavis, John
    Iorio, Alfonso
    Little, Julian
    [J]. VACCINE, 2023, 41 (43) : 6411 - 6418
  • [8] Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19
    Linkins, Lori-Ann
    Iorio, Alfonso
    Little, Julian
    Lavis, John
    [J]. VACCINE, 2022, 40 (22) : 2986 - 2987
  • [9] COVID-19 vaccine rollout: will it affect the rates of vaccine hesitancy in Africa?
    Ekwebelem, O. C.
    Yunusa, I.
    Onyeaka, H.
    Ekwebelem, N. C.
    Nnorom-Dike, O.
    [J]. PUBLIC HEALTH, 2021, 197 : E18 - E19
  • [10] COVID-19 vaccine willingness prior to and during the COVID-19 vaccination rollout in Australia
    Wang, Bing
    Nolan, Rebecca
    Krumeich, Benjamin
    D'Onise, Katina
    Marshall, Helen
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)